44 related articles for article (PubMed ID: 26751593)
1. Interaction with CT-DNA and in vitro cytotoxicity of two new copper(II)-based potential drugs derived from octanoic hydrazide ligands.
Chowdhury M; Biswas N; Saha S; Rahaman A; Gupta PS; Banerjee A; Mandal DP; Bhattacharjee S; Zangrando E; Sciortino G; Pisanu F; Garribba E; Roy Choudhury R; Roy Choudhury C
J Inorg Biochem; 2024 Jul; 256():112546. PubMed ID: 38593611
[TBL] [Abstract][Full Text] [Related]
2. DNA-Binding and Anticancer Activity of Binuclear Gold(I) Alkynyl Complexes with a Phenanthrenyl Bridging Ligand.
Alsaeedi MS; Babgi BA; Hussien MA; Abdellattif MH; Humphrey MG
Molecules; 2020 Feb; 25(5):. PubMed ID: 32106590
[TBL] [Abstract][Full Text] [Related]
3. The Therapeutic Potential in Cancer of Terpyridine-Based Metal Complexes Featuring Group 11 Elements.
Gil-Moles M; Concepción Gimeno M
ChemMedChem; 2024 May; 19(10):e202300645. PubMed ID: 38328860
[TBL] [Abstract][Full Text] [Related]
4. Novel binuclear copper(II) complexes with sulfanylpyrazole ligands: synthesis, crystal structure, fungicidal, cytostatic, and cytotoxic activity.
Akhmetova VR; Akhmadiev NS; Gubaidullin AT; Samigullina AI; Glazyrin AB; Sadykov RA; Ishmetova DV; Vakhitova YV
Metallomics; 2024 Jun; 16(6):. PubMed ID: 38802123
[TBL] [Abstract][Full Text] [Related]
5. Newly synthesized palladium(II) complexes with dialkyl esters of (
Ćorović K; Stojković DL; Petrović ĐS; Jovičić Milić SS; Đukić MB; Radojević ID; Raković I; Jurišević M; Gajović N; Jovanović M; Marinković J; Jovanović I; Stojanović B
Dalton Trans; 2024 May; 53(18):7922-7938. PubMed ID: 38644680
[TBL] [Abstract][Full Text] [Related]
6. The influence of thioether-substituted ligands in dicopper(II) complexes: Enhancing oxidation and biological activities.
Durigon DC; Glitz VA; Pimenta BF; Guedes AMV; Silva JVO; Bella Cruz CC; Andrade LM; Pereira-Maia EC; Mikcha JMG; Bella Cruz A; Xavier FR; Terenzi HF; Poneti G; Ribeiro RR; Nordlander E; Caramori GF; Bortoluzzi AJ; Peralta RA
J Inorg Biochem; 2024 Jul; 256():112573. PubMed ID: 38678913
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of substituted terpyridine nickel nitrate complexes and their inhibitory selectivity against cancer cell lines.
Huang X; Wang B; Sun D; Chen M; Xue X; Liu H; Zhou Y; Ma Z
J Inorg Biochem; 2024 Jul; 256():112554. PubMed ID: 38613885
[TBL] [Abstract][Full Text] [Related]
8. Copper(II) Complexes with 2,2':6',2″-Terpyridine Derivatives Displaying Dimeric Dichloro-μ-Bridged Crystal Structure: Biological Activities from 2D and 3D Tumor Spheroids to In Vivo Models.
Choroba K; Machura B; Erfurt K; Casimiro AR; Cordeiro S; Baptista PV; Fernandes AR
J Med Chem; 2024 Apr; 67(7):5813-5836. PubMed ID: 38518246
[TBL] [Abstract][Full Text] [Related]
9. Copper and Copper Complexes in Tumor Therapy.
Wang Y; Tang T; Yuan Y; Li N; Wang X; Guan J
ChemMedChem; 2024 Jun; 19(11):e202400060. PubMed ID: 38443744
[TBL] [Abstract][Full Text] [Related]
10. Biological Activity of Triazolopyrimidine Copper(II) Complexes Modulated by an Auxiliary N-N-Chelating Heterocycle Ligands.
Ruta LL; Farcasanu IC; Bacalum M; Răileanu M; Rostas AM; Daniliuc C; Chifiriuc MC; Măruțescu L; Popa M; Badea M; Iorgulescu EE; Olar R
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833864
[TBL] [Abstract][Full Text] [Related]
11. Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review.
Abdolmaleki S; Aliabadi A; Khaksar S
J Cancer Res Clin Oncol; 2024 Apr; 150(4):213. PubMed ID: 38662225
[TBL] [Abstract][Full Text] [Related]
12. Nuclease activity via self-activation and anticancer activity of a mononuclear copper(II) complex: novel role of the tertiary butyl group in the ligand frame.
Ghosh K; Kumar P; Mohan V; Singh UP; Kasiri S; Mandal SS
Inorg Chem; 2012 Mar; 51(6):3343-5. PubMed ID: 22372979
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and crystal structure of new dicopper(II) complexes having asymmetric N,N'-bis(substituted)oxamides with DNA/protein binding ability: In vitro anticancer activity and molecular docking studies.
Zheng K; Zhu L; Li YT; Wu ZY; Yan CW
J Photochem Photobiol B; 2015 Aug; 149():129-42. PubMed ID: 26057022
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure elucidation of new μ-oxamido-bridged dicopper(II) complexes showing in vitro anticancer activity: Evaluation of DNA/protein-binding properties by experiment and molecular docking.
Zheng K; Liu F; Li YT; Wu ZY; Yan CW
J Inorg Biochem; 2016 Mar; 156():75-88. PubMed ID: 26775278
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure elucidation of new μ-oxamido-bridged dicopper(II) complex with in vitro anticancer activity: A combined study from experiment verification and docking calculation on DNA/protein-binding property.
Zhu L; Zheng K; Li YT; Wu ZY; Yan CW
J Photochem Photobiol B; 2016 Feb; 155():86-97. PubMed ID: 26773872
[TBL] [Abstract][Full Text] [Related]
16. Interaction of DNA with Simple and Mixed Ligand Copper(II) Complexes of 1,10-Phenanthrolines as Studied by DNA-Fiber EPR Spectroscopy.
Chikira M; Ng CH; Palaniandavar M
Int J Mol Sci; 2015 Sep; 16(9):22754-80. PubMed ID: 26402668
[TBL] [Abstract][Full Text] [Related]
17. 1,8-Naphthalimide: A Potent DNA Intercalator and Target for Cancer Therapy.
Tandon R; Luxami V; Kaur H; Tandon N; Paul K
Chem Rec; 2017 Oct; 17(10):956-993. PubMed ID: 28375569
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure of new dicopper(II) complexes bridged by N-(2-hydroxy-5-methylphenyl)-N'-[3-(dimethylamino)propyl]oxamide with in vitro anticancer activity: A comparative study of reactivities towards DNA/protein by molecular docking and experimental assays.
Zheng K; Yan MX; Li YT; Wu ZY; Yan CW
Eur J Med Chem; 2016 Feb; 109():47-58. PubMed ID: 26751593
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
